Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
出版年份 2015 全文链接
标题
Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
作者
关键词
-
出版物
EUROPEAN HEART JOURNAL
Volume 36, Issue 15, Pages 915-923
出版商
Oxford University Press (OUP)
发表日期
2015-02-01
DOI
10.1093/eurheartj/ehu504
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. CIRCULATION
- Impact of Physical Activity on Cardiovascular Events in Patients With Chronic Heart Failure
- (2013) Yutaka Miura et al. CIRCULATION JOURNAL
- Usefulness of Combined Risk Stratification With Heart Rate and Systolic Blood Pressure in the Management of Chronic Heart Failure
- (2013) Masanobu Miura et al. CIRCULATION JOURNAL
- Epidemiology of Heart Failure in Asia
- (2013) Yasuhiko Sakata et al. CIRCULATION JOURNAL
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial—Rationale and design
- (2013) Yasuhiko Sakata et al. Journal of Cardiology
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
- (2013) H. Makani et al. BMJ-British Medical Journal
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
- (2012) et al. EUROPEAN HEART JOURNAL
- Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study
- (2012) Masanobu Miura et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
- (2012) Kazuhiro Yamamoto et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
- (2012) Lars H. Lund et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trend of Westernization of Etiology and Clinical Characteristics of Heart Failure Patients in Japan
- (2011) Nobuyuki Shiba et al. CIRCULATION JOURNAL
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction
- (2011) Inder S. Anand et al. Circulation-Heart Failure
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Both High and Low Body Mass Indexes are Prognostic Risks in Japanese Patients With Chronic Heart Failure: Implications From the CHART Study
- (2010) Kotaro Nochioka et al. JOURNAL OF CARDIAC FAILURE
- Epidemiology and risk profile of heart failure
- (2010) Anh L. Bui et al. Nature Reviews Cardiology
- Emerging Problems of Heart Failure Practice in Japanese Women
- (2008) Nobuyuki Shiba et al. CIRCULATION JOURNAL
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started